Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|April 15, 2006
Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesisXin Mao, Guy Orchard, Eric C Vonderheid, et al.
The Journal of Investigative Dermatology|March 27, 2019
Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 ResistanceRosie M Butler, Robert C McKenzie, Christine L Jones, et al.
Journal of Cutaneous Pathology|May 23, 2008
A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SSXin Mao, Guy Orchard, Tracey J Mitchell, et al.
The Journal of Investigative Dermatology|August 4, 2019
Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT SignalingVarsha M Patel, Charlotte E Flanagan, Marta Martins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphomaSean J Whittaker, Marie-France Demierre, Ellen J Kim, et al.
The Journal of Investigative Dermatology|February 14, 2016
Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell LymphomaWesley J Woollard, Nithyha P Kalaivani, Christine L Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposalNita Sally Agar, Emma Wedgeworth, Siobhan Crichton, et al.
Leukemia & Lymphoma|January 14, 2012
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibitionReinhard Dummer, Marc Beyer, Kenneth Hymes, et al.
Blood|May 8, 2010
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potentialErica Ballabio, Tracey Mitchell, Marloes S van Kester, et al.
The Journal of Investigative Dermatology|November 21, 2008
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg typeNancy J Senff, Willem H Zoutman, Maarten H Vermeer, et al.
Pageof 4